Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 56.00
-4.00 (-6.67%)
May 8, 2026, 1:58 PM CST
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 11.2 billion as of May 8, 2026. Its market cap has increased by 155.77% in one year.
Market Cap
11.20B
Enterprise Value
10.75B
Revenue
12.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
56.00
Market Cap Chart
Since April 28, 2022, Locus Cell's market cap has increased from 9.88B to 11.20B, an increase of 13.39%. That is a compound annual growth rate of 3.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 11.20B | 94.78% |
| Dec 31, 2025 | 5.75B | 44.14% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
| Apr 28, 2022 | 9.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medigen Vaccine Biologics | 15.90B |
| Polaris Group | 15.52B |
| AP Biosciences | 14.85B |
| EirGenix | 13.95B |
| TaiMed Biologics | 13.36B |
| CHO Pharma | 12.24B |
| Ever Supreme Bio Technology | 12.13B |
| Tanvex BioPharma | 10.58B |